Literature DB >> 11212121

Anti-Helicobacter pylori agents endowed with H2-antagonist properties.

G Sorba1, M Bertinaria, A Di Stilo, A Gasco, M M Scaltrito, M I Brenciaglia, F Dubini.   

Abstract

New anti-Helicobacter pylori (H. pylori) agents endowed with H2-antagonists properties were obtained by combining the lamtidine derived pharmacophoric group with the antibiotic calvatic acid. All the compounds were tested for their irreversible H2-antagonist properties and for their ability to inhibit 20 H. pylori strains, two of them metronidazole resistant. The most active derivative (compound 4) displayed antimicrobial activity similar to metronidazole.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11212121     DOI: 10.1016/s0960-894x(00)00671-5

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

Review 1.  Medicinal plant activity on Helicobacter pylori related diseases.

Authors:  Yuan-Chuen Wang
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

2.  In-silico design, synthesis, ADMET studies and biological evaluation of novel derivatives of Chlorogenic acid against Urease protein and H. Pylori bacterium.

Authors:  Ritu Kataria; Anurag Khatkar
Journal:  BMC Chem       Date:  2019-03-28

3.  Novel essential amino acid-sulfanilamide hybrid as safe anti-ulcerogenic agent with anti-helicobacter pylori activity.

Authors:  Amani S Awaad; Ahmed M Alafeefy; Fatmah A S Alasmary; Reham M El-Meligy; M E Zain; Saleh I Alqasoumi
Journal:  Saudi Pharm J       Date:  2017-02-27       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.